Clearside Biomedical Inc. (CLSD) Fundamentals

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.
SHARE INFORMATION
Market Cap$ 80,053,672
Shares Outstanding60,190,731
Float54,481,778
Percent Float90.52%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 29,575,000
Latest Fiscal EPS$ 0.01
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions118
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months39,457
Institutional Holdings Percent35.7%
Institutional Sold Previous 3 Months1,616,533
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months76,158
Insider Holdings Percent9.1
Insider Sold Previous 3 Months1,463,016
Insider Shares Owned5,483,623
TRADING INFO
52 Week High$ 2.85
52 Week Low$ 0.98
52 Week High Change$ -27.72
21 Day Moving Average$ 1.4355
21 Day Extended Moving Average$ 1.4063
50 Day Moving Average$ 1.2809
50 Day Extended Moving Average$ 1.3367
200 Day Moving Average$ 1.4003
200 Day Extended Moving Average$ 1.5852
10 Day Average Volume155,658
20 Day Average Volume244,860
30 Day Average Volume299,692
50 Day Average Volume244,042
Alpha0.003920
Beta1.8365
Standard Deviation0.324164
R20.093332
7 Day Price Change$ -0.17
7 Day Percent Change-11.33%
21 Day Price Change$ -0.31
21 Day Percent Change-18.9%
30 Day Price Change$ 0.22
30 Day Percent Change19.82%
Month to Date Price Change$ 0.21
Month to Date Percent Change18.75%
Quarter to Date Price Change$ 0.21
Quarter to Date Percent Change18.75%
180 Day Price Change$ -0.32
180 Day Percent Change-19.39%
200 Day Price Change$ -0.36
200 Day Percent Change-21.3%
Year to Date Price Change$ 0.21
Year to Date Percent Change18.75%

Clearside Biomedical Inc. (CLSD) Key Ratios

PROFITABILITY
EBIT Margin-16.0%
EBITDA Margin-15.4%
Pre-Tax Profit Margin-58,945.6%
Profit Margin Count-26.16%
Gross Margin0.0%
Profit Margin TOT-26.16%
INCOME STATEMENTS
Revenue$ 997,000
Revenue Per Share$ 0.0166
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.30
Total Debt To Equity0.00
Int Coverage-2.50
Current Ratio10.50
Leverage Ratio1.70
Quick Ratio10.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-22.20
Enterprise Value$ 27,079,672
Price to Sales80.2946
Price to Free Cash-10.10
PE High Last 5 Years-1.50
Price To Book4.30
Price To Cash Flow399.40
PE Low Last 5 Years-5.50
Price to Tangible Book4.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-11.60
Return on Equity-27.18
Return on Capital-24.36

Clearside Biomedical Inc. (CLSD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOGeorge Lasezkay
Emplyoees34
Last AuditUQ
CIK0001539029
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address900 North Point Parkway
Suite 200
Alpharetta, GA 30005
Websitehttps://www.clearsidebio.com
Facsimile+1 678 270-4033
Telephone+1 678 270-3631
Emailir@clearsidebio.com
Your Recent History
NASDAQ
CLSD
Clearside ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230131 17:50:31